These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 899941
1. Evidence for a relationship between plasma immunoreactive calcitonin and bone disease in chronic renal failure. Kanis JA, Heynen G, Earnshaw M, Russell RG, Woods CG, Franchimont P, Gaspar S, Oliver D, Ledingham JG. Adv Exp Med Biol; 1977; 81():571-9. PubMed ID: 899941 [No Abstract] [Full Text] [Related]
5. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy]. Bucciante G, Bernardi A, Biasia F, Milan G, Donato D. Minerva Med; 1985 Mar 10; 76(9-10):415-7. PubMed ID: 3982698 [No Abstract] [Full Text] [Related]
9. Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders. Ahmed KY, Varghese Z, Meinhard EA, Baillod RA, Skinner RK, Wills MR, Moorhead JF. Adv Exp Med Biol; 1977 Mar 10; 81():581-90. PubMed ID: 899942 [No Abstract] [Full Text] [Related]
10. Renal bone disease in patients on haemodialysis: biochemical and radiological assessment. Lye WC, Lee EJ. Ann Acad Med Singap; 1992 Nov 10; 21(6):760-4. PubMed ID: 1295414 [Abstract] [Full Text] [Related]
11. Target levels for serum phosphorus and parathyroid hormone. Qunibi W, Kalantar-Zadeh K. Semin Dial; 2011 Nov 10; 24(1):29-33. PubMed ID: 21324001 [No Abstract] [Full Text] [Related]
12. [Immunoreactive parathyroid hormone, 25-hydroxycalciferol and bone histology in renal osteodystrophy (author's transl)]. Offermann G, Schaefer K, Schulz A, Delling G. Klin Wochenschr; 1976 Jul 01; 54(13):625-32. PubMed ID: 940299 [Abstract] [Full Text] [Related]
14. Evidence that endogenous calcitonin protects against renal bone disease. Kanis JA, Oliver D, Ledingham JC, Russell RG. Lancet; 1976 Dec 18; 2(7999):1322-6. PubMed ID: 63802 [Abstract] [Full Text] [Related]
16. [Diagnostic accuracy study comparing total alkaline phosphatase with intact parathyroid hormone 1-84 for the diagnosis of high turnover renal osteodystrophy in chronic renal failure on hemodialysis]. Rojas González AM, Opazo Valenzuela M, Muñoz Navarro S. Medwave; 2014 Sep 03; 14(8):e6014. PubMed ID: 25340338 [Abstract] [Full Text] [Related]
17. Comparison of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis and hemodialysis. Anwar N, Hutchison AJ, Gokal R. Perit Dial Int; 1993 Sep 03; 13 Suppl 2():S451-3. PubMed ID: 8399637 [No Abstract] [Full Text] [Related]
18. Osteodystrophy of dialysed patients treated with vitamin D. Verberckmoes R, Bouillon R, Krempien B. Proc Eur Dial Transplant Assoc; 1973 Sep 03; 10(0):217-26. PubMed ID: 4370246 [No Abstract] [Full Text] [Related]
19. [Hormonal markers of early-stage osteitis fibrosa in patients on hemodialysis]. Persichetti S, Sagliaschi G, Clemenzia G, Angelitti A, Gallo G, Maggi S, Ponzio R, Punzo G, Tozzo C. Minerva Med; 1992 Nov 03; 83(11):721-4. PubMed ID: 1461543 [Abstract] [Full Text] [Related]